Tag: biotechnology
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.
-
Limited Covid-19 Benefits Found for Arthritis Drug
A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections.
-
Trial Okayed in Germany for Covid-19 Vaccine
Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections.
-
Fast, Simple Covid-19 Antibody Test Being Developed
An engineering lab is creating an easy-to-use test of immune-system antibodies to the SARS-Cov-2 virus responsible for Covid-19 infections.
-
Infographic – Biotech Remains Hottest Venture Sector
A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars.
-
Venture Deals Decline in Q1, Biotech Sizzles Again
The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors.
-
Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-
Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-
Anti-Viral Drug Treats Some Severe Covid-19 Cases
A report of early use of the anti-viral therapy remdesivir shows most patients with severe cases of Covid-19 infections responded to the drug.